🇺🇸 FDA

Intelligence · Patent portfolio

ENANTA PHARMACEUTICALS Patents

Full USPTO pharma patent portfolio for ENANTA PHARMACEUTICALS — grant dates, expiration, and drug cross-links.

Patents
218
Expiring ≤24m
9

Quick answer

ENANTA PHARMACEUTICALS has 218 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 9 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 5

  1. US 10968249

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10952978

    Hepatitis B antiviral agents

    Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10934306

    Hepatitis B antiviral agents

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10881666

    Combination pharmaceutical agents as RSV inhibitors

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10865211

    Functionalized heterocycles as antiviral agents

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10865215

    Benzodiazepine derivatives as RSV inhibitors

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10851115

    Heterocyclic compounds as RSV inhibitors

    Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10829486

    Isoxazole derivatives as FXR agonists and methods of use thereof

    Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10759816

    Heterocyclic compounds as RSV inhibitors

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10752598

    Aryldiazepine derivatives as RSV inhibitors

    Expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10738035

    Hepatitis B antiviral agents

    Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10729688

    Hepatitis B antiviral agents

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10723733

    Hepatitis B antiviral agents

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10702528

    Hepatitis B antiviral agents

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10696713

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10683279

    Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10647711

    Azepin-2-one derivatives as RSV inhibitors

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10640511

    Hepatitis B antiviral agents

    Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10597391

    Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof

    Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10597382

    Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10570153

    Benzodiazepine derivatives as RSV inhibitors

    Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10538532

    Hepatitis B antiviral agents

    Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10519191

    Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

    Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10472386

    Bile acid derivatives as FXR agonists and methods of use thereof

    Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10457703

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10450306

    Isoxazole analogs as FXR agonists and methods of use thereof

    Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10442788

    Hepatitis B antiviral agents

    Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10428070

    Hepatitis B antiviral agents

    Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10407445

    Hepatitis C virus inhibitors

    Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10398706

    Heteroaryldiazepine derivatives as RSV inhibitors

    Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10323061

    Heteroaryl containing bile acid analogs as FXR/TGR5 agonists and methods of use thereof

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10301255

    Hepatitis B antiviral agents

    Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10280175

    Hepatitis B antiviral agents

    Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10266560

    Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10246483

    Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

    Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10208081

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10189846

    Hepatitis B antiviral agents

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10179131

    Hepatitis B antiviral agents

    Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10179792

    Hepatitis B antiviral agents

    Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10144729

    Isoxazole analogs as FXR agonists and methods of use thereof

    Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10138228

    Isoxazole derivatives as FXR agonists and methods of use therof

    Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10080743

    Isoxazole derivatives as FXR agonists and methods of use thereof

    Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10080742

    Isoxazole derivatives as FXR agonists and methods of use thereof

    Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10080741

    Isoxazole derivatives as FXR agonists and methods of use thereof

    Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10034893

    5, 6-D2 uridine nucleoside/tide derivatives

    Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10017499

    Benzimidazole derivatives

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9957281

    Benzodiazepine derivatives as RSV inhibitors

    Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9765087

    Benzimidazole derivatives

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does ENANTA PHARMACEUTICALS have?

218 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do ENANTA PHARMACEUTICALS patents expire?

9 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.